Latest Market Positioning News

Sayona Mining reports solid FY25 operational gains and outlines strategic merger progress with Piedmont Lithium, positioning itself as a leading North American lithium producer amid a recovering market.

Almonty Industries posted a modest revenue rise in Q1 2025 but faced a steep net loss due to warrant revaluation, while securing key U.S. defense contracts and advancing its flagship Sangdong tungsten mine.

Red Mountain Mining has initiated a 1000m reverse circulation drilling program at its Kiabye Gold Project in Western Australia, aiming to test newly identified magnetic anomalies and historic gold zones. The program is backed by recent capital raising and coincides with ongoing sampling at its Armidale Antimony-Gold Project.

State Street Global Advisors updates its SPDR Fixed Income ETFs with new iBoxx branding and significant fee reductions effective June 2025, enhancing cost competitiveness for investors.

State Street Global Advisors announces significant fee reductions and rebranding for its SPDR Australian Bond ETFs, aligning with the iBoxx index series to enhance market positioning and investor appeal.

NSX Limited has entered a Scheme Implementation Deed with CNSX Markets Inc. for a full acquisition at a 59% premium, subject to shareholder and regulatory approvals. The deal aims to strengthen NSX’s market position and expand its product offerings.

Vitura Health’s joint venture Flora Holdings has acquired Heyday Medical Clinic, a leading medicinal cannabis provider, enhancing its national clinical network and patient access across Australia.

Lendlease has partnered with The Crown Estate to create a 50/50 joint venture aimed at accelerating capital recycling of over $300 million through UK commercial and residential developments. The deal also includes a $1.2 billion Australian office investment mandate, boosting Lendlease’s funds under management to $20 billion.

ITM Isotope Technologies Munich SE and Radiopharm Theranostics have entered a strategic supply agreement for the critical radioisotope Lutetium-177, underpinning Radiopharm’s clinical development of targeted cancer therapies.

Gentrack Group Ltd reported a robust 9.8% revenue increase and a 34.7% jump in net profit for the first half of FY25, driven by strong recurring revenues and strategic global expansion.

Osteopore Limited has increased its capital raise by drawing down an additional A$500,000 on its Tranche 1 redeemable convertible notes, bringing total subscriptions to A$3.5 million. The funds will support ongoing operations and future growth initiatives.

Dicker Data announces the departure of co-founder David Dicker from CEO and Chairman roles, transitioning leadership to a seasoned executive team under co-founder Fiona Brown’s Executive Chairmanship.